Results 221 to 230 of about 1,594,352 (310)

Predictive value of HMGB1 for atrial fibrillation recurrence after cryoballoon ablation in paroxysmal atrial fibrillation patients

open access: yesClinical Cardiology, Volume 45, Issue 12, Page 1229-1235, December 2022., 2022
Abstract Background Cryoballoon ablation (CBA) is recommended for patients with symptomatic drug refractory paroxysmal atrial fibrillation (pAF). However, substantial atrial fibrillation (AF) recurrence is common during follow‐up. Searching for a potential biomarker representing both myocardial injury and inflammation to identify patients at high risk ...
Xinxin Li   +9 more
wiley   +1 more source

Endocrine-Disrupting Chemicals and the Development of Diabetes Mellitus Type 1: A 5-Year Systematic Review. [PDF]

open access: yesInt J Mol Sci
Keskesiadou GN   +6 more
europepmc   +1 more source

A remote hypertension management program clinical algorithm

open access: yesClinical Cardiology, Volume 45, Issue 12, Page 1147-1162, December 2022., 2022
Abstract Introduction Hypertension is the leading risk factor for death, affecting over one billion people worldwide, yet control rates are poor and stagnant. We developed a remote hypertension management program that leverages digitally transmitted home blood pressure (BP) measurements, algorithmic care pathways, and patient–navigator communications ...
Hunter Nichols   +3 more
wiley   +1 more source

Safety of teplizumab in patients with high-risk for diabetes mellitus type 1: A systematic review. [PDF]

open access: yesWorld J Diabetes
Buddhavarapu V   +5 more
europepmc   +1 more source

Flavonoid‐Derived Probes for the Detection of Islet Amyloid Polypeptide Aggregates

open access: yesAnalysis &Sensing, EarlyView.
Misfolding and aggregation of islet amyloid polypeptide (IAPP) has been implicated in Type‐2 diabetes (T2D), contributing to β‐cell dysfunction. We developed flavonoid‐based probes, F4 and MF1, for detecting IAPP fibrils. These probes showed improved fluorescence response, over 10‐fold higher binding affinity than Thioflavin T and enabled specific ...
Zijie Luo   +6 more
wiley   +1 more source

Association between serum cystatin C and early impairment of cardiac function and structure in type 2 diabetes patients with normal renal function

open access: yesClinical Cardiology, Volume 45, Issue 12, Page 1287-1296, December 2022., 2022
Abstract Background Type 2 diabetes mellitus (T2DM) patients may have cardiac remodeling and dysfunction from the early stage of disease. This study aimed to determine the association between cystatin C (CysC) and early cardiac functional or structural impairment in T2DM patients without renal dysfunction.
Zhuoshan Huang   +10 more
wiley   +1 more source

Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10‐Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS Remission

open access: yesArthritis &Rheumatology, EarlyView.
Objective Cardiovascular disease (CVD) is a leading cause of death in individuals with systemic lupus erythematosus (SLE). We assessed atherosclerotic plaque progression and incident cardiovascular events in patients with SLE over a 10‐year follow‐up.
Nikolaos Papazoglou   +2 more
wiley   +1 more source

Clinical Relevance of Drug–Drug Interactions With Antibiotics as Listed in a National Medication Formulary: Results From Two Large Population‐Based Case‐Control Studies in Patients Aged 65–100 Years Using Linked English Primary Care and Hospital Data

open access: yesClinical Pharmacology &Therapeutics, Volume 113, Issue 2, Page 423-434, February 2023., 2023
This study evaluated drug–drug interactions (DDIs) between antibiotic and nonantibiotic drugs listed with warnings of severe outcomes in the British National Formulary based on adverse drug reaction (ADR) detectable with routine International Classification of Diseases, Tenth Revision coding.
Tjeerd Pieter van Staa   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy